台灣臨床試驗主持人資料庫|TPIDB

2018-06-01 - 2023-03-21

Phase III

Completed

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease

Condition/Disease

Alzheimer Disease
Test Drug

GANTENERUMAB

Participate Sites
8Sites

Terminated6Sites

劉景寬

Kaohsiung Municipal Gangshan Hospital

未分科

黃錦章

Linkou Chang Gung Medical Foundation

Division of Neurology

2015-06-23 - 2017-04-12

Phase II

Not yet recruiting

Condition/Disease
Test Drug

Participate Sites
4Sites

Terminated3Sites

陳彥旭

Kaohsiung Municipal Gangshan Hospital

未分科

2017-06-01 - 2026-08-31

Phase III

Completed

A Randomized, Double-Blind, Placebo Controlled Phase 3 Study of Venetoclax Co-Administered With Low Dose Cytarabine Versus Low Dose Cytarabine in Treatment Naïve Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Condition/Disease

Acute Myeloid Leukemia
Test Drug

Venetoclax (ABT-199/GDC-0199)

Participate Sites
5Sites

Terminated4Sites

2016-09-19 - 2019-08-23

Phase II/III

Completed

Randomized, Double-Blind, Phase 2/3 Study in Subjects with Malignant Pleural Mesothelioma with Low Argininosuccinate Synthetase 1 Expression to Assess ADI-PEG 20 with Pemetrexed and Cisplatin (ATOMIC-Meso Phase 2/3 Study)

Condition/Disease

methothlioma
Test Drug

ADI-PEG 20

Participate Sites
7Sites

Terminated6Sites

鍾飲文

Kaohsiung Municipal Gangshan Hospital

未分科

2015-10-01 - 2017-07-31

Phase I/II

Completed

A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus

Condition/Disease

Staphylococcus Aureus bacteremia
Test Drug

514G3

Participate Sites
6Sites

Terminated4Sites

陳彥旭

Kaohsiung Municipal Gangshan Hospital

未分科

2016-09-01 - 2020-11-09

Phase II

A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE II STUDY OF THE EFFICACY AND SAFETY OF TRASTUZUMAB EMTANSINE IN COMBINATION WITH ATEZOLIZUMAB OR ATEZOLIZUMAB-PLACEBO IN PATIENTS WITH HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER WHO HAVE RECEIVED PRIOR TRASTUZUMAB AND TAXANE BASED THERAPY.

Condition/Disease

HER2-POSITIVE LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Test Drug

KADCYLA

Participate Sites
10Sites

Terminated8Sites

侯明鋒

Kaohsiung Municipal Gangshan Hospital

未分科

曾令民

Taipei Veterans General Hospital

Division of General Surgery

2016-02-21 - 2020-12-31

Phase III

A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ATEZOLIZUMAB (ANTI-PD-L1 ANTIBODY) IN COMBINATION WITH NAB-PACLITAXEL COMPARED WITH PLACEBO WITH NAB-PACLITAXEL FOR PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC TRIPLE NEGATIVE BREAST CANCER

Condition/Disease

Triple Negative Breast Cancer (TNBC)
Test Drug

Atezolizumab

Participate Sites
6Sites

Not yet recruiting1Sites

Terminated3Sites

侯明鋒

Kaohsiung Municipal Gangshan Hospital

未分科

曾令民

Taipei Veterans General Hospital

Division of General Surgery

2019-03-01 - 2023-10-07

Phase II

The HIV Functional Cure Potential of UB-421: A Phase II, Randomized, Open-label, Controlled, 48 Week, Proof of Concept Study, to Evaluate the Safety of UB-421 in Combination With Standard Antiretroviral Therapy (ART) and the Efficacy of HIV Reservoir Reduction as Compared With ART Alone in ART Stabilized HIV-1 Patients

Condition/Disease

HIV-1 Infection
Test Drug

UB-421

Participate Sites
6Sites

Not yet recruiting1Sites

Recruiting4Sites

陳彥旭

Kaohsiung Municipal Gangshan Hospital

未分科

2019-01-01 - 2024-05-17

Phase III

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) plus Platinum and Fluoropyrimidine Versus Placebo plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Condition/Disease

Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Test Drug

Tislelizumab

Participate Sites
4Sites

Recruiting3Sites

王照元

Kaohsiung Municipal Gangshan Hospital

未分科

趙毅

Taipei Veterans General Hospital

2017-05-15 - 2020-04-09

Phase III

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects With Extensive Stage Small Cell Lung Cancer (MERU)

Condition/Disease

Extensive Stage Small Cell Lung Cancer
Test Drug

Rovalpituzumab Tesirine(Rova-T)

Participate Sites
9Sites

Terminated8Sites

洪仁宇

Kaohsiung Municipal Gangshan Hospital

未分科

邱昭華

Taipei Veterans General Hospital

Division of Hematology & Oncology

Search Result

List